Company intelligence / Profile preview

OrbiMed Israel Incubator Limited Partnership

Herzliya, Israel

Ownership: Private
Development stage: Other

Overview

OrbiMed Israel Incubator is an active investment vehicle and incubator under OrbiMed Advisors, specializing in early-stage Israeli life science companies (biotech, pharma, medtech). Launched in 2011, it is associated with the FuturRx incubator initiative, partnering with Johnson & Johnson Innovation - JJDC and Takeda Ventures Inc. Its first fund invested $130M in 19 Israeli companies, achieving a 21.4% IRR, and plans for a second $250M fund. As an incubator/VC, it does not have a direct therapeutic pipeline.

Industry: Investors

Partnerships

Johnson & Johnson Innovation - JJDCTakeda Ventures Inc.Office of the Chief Scientist of the Ministry of Economy

Beyond the preview

Go deeper on OrbiMed Israel Incubator Limited Partnership.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrbiMed Israel Incubator Limited Partnership.

Explore the full profile